Bessemer Group Inc. Has $861,000 Stake in The Clorox Company $CLX

Bessemer Group Inc. lowered its stake in The Clorox Company (NYSE:CLX) by 43.8% in the first quarter, Holdings Channel reports. The fund owned 8,307 shares of the company’s stock after selling 6,462 shares during the quarter. Bessemer Group Inc.’s holdings in Clorox were worth $861,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Darwin Wealth Management LLC acquired a new stake in Clorox in the second quarter valued at approximately $29,000. Caitlin John LLC increased its holdings in shares of Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after buying an additional 253 shares in the last quarter. Root Financial Partners LLC lifted its stake in shares of Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after acquiring an additional 145 shares during the last quarter. Vision Financial Markets LLC boosted its holdings in shares of Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after acquiring an additional 200 shares in the last quarter. Finally, SHP Wealth Management bought a new stake in Clorox during the 4th quarter worth $35,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Price Performance

Shares of CLX opened at $93.81 on Friday. The business has a 50-day moving average of $95.00 and a 200-day moving average of $103.89. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The company has a market capitalization of $11.34 billion, a price-to-earnings ratio of 15.23 and a beta of 0.54. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.00.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s revenue was up .1% on a year-over-year basis. During the same period in the prior year, the business posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 5.52 earnings per share for the current year.

Insider Activity at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on CLX. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. JPMorgan Chase & Co. lowered their price objective on Clorox from $95.00 to $92.00 and set an “underweight” rating for the company in a research note on Thursday, July 16th. Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $94.00 target price on shares of Clorox in a research report on Wednesday. Finally, Jefferies Financial Group decreased their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat, Clorox presently has a consensus rating of “Reduce” and an average price target of $102.80.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.